Danske Bank A S Reduces Position in Molina Healthcare, Inc $MOH

Danske Bank A S reduced its stake in Molina Healthcare, Inc (NYSE:MOH) by 91.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 2,400 shares of the company’s stock after selling 26,016 shares during the quarter. Danske Bank A S’s holdings in Molina Healthcare were worth $416,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Torren Management LLC bought a new position in shares of Molina Healthcare in the fourth quarter worth about $26,000. Miller Global Investments LLC bought a new position in shares of Molina Healthcare during the 4th quarter valued at approximately $27,000. Cromwell Holdings LLC increased its holdings in Molina Healthcare by 211.9% in the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after acquiring an additional 125 shares in the last quarter. Bogart Wealth LLC purchased a new stake in Molina Healthcare in the 3rd quarter worth approximately $39,000. Finally, Rakuten Securities Inc. raised its stake in Molina Healthcare by 5,020.0% during the 4th quarter. Rakuten Securities Inc. now owns 256 shares of the company’s stock worth $44,000 after acquiring an additional 251 shares during the period. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on MOH shares. Bank of America raised shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price target on the stock in a report on Wednesday, April 29th. Cantor Fitzgerald reduced their price objective on shares of Molina Healthcare from $180.00 to $144.00 and set a “neutral” rating for the company in a research note on Monday, February 9th. Weiss Ratings restated a “sell (d+)” rating on shares of Molina Healthcare in a research report on Tuesday, April 21st. The Goldman Sachs Group dropped their target price on shares of Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a report on Wednesday, February 11th. Finally, Barclays increased their price target on Molina Healthcare from $133.00 to $161.00 and gave the stock an “underweight” rating in a research note on Friday, April 24th. Three research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $169.60.

Molina Healthcare Trading Down 1.7%

MOH stock opened at $192.25 on Wednesday. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $333.00. The business has a 50 day simple moving average of $150.65 and a two-hundred day simple moving average of $158.47. The company has a market capitalization of $10.02 billion, a price-to-earnings ratio of 56.88 and a beta of 0.85.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. During the same quarter in the previous year, the firm earned $6.08 earnings per share. The company’s quarterly revenue was down 3.1% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Research analysts anticipate that Molina Healthcare, Inc will post 5.21 EPS for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.